Repligen Net Income
| RGEN Stock | USD 143.19 0.39 0.27% |
As of the 10th of February, Repligen holds the Risk Adjusted Performance of 0.0017, variance of 4.63, and Coefficient Of Variation of (17,674). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Repligen, as well as the relationship between them.
Repligen Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 11.3439 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -29.3 M | -30.8 M | |
| Net Income Applicable To Common Shares | 213.9 M | 224.5 M | |
| Net Loss | -29.3 M | -27.9 M | |
| Net Loss | (0.41) | (0.39) | |
| Net Income Per E B T | 1.09 | 1.17 |
Repligen | Net Income | Build AI portfolio with Repligen Stock |
Evaluating Repligen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Repligen's fundamental strength.
Latest Repligen's Net Income Growth Pattern
Below is the plot of the Net Income of Repligen over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Repligen financial statement analysis. It represents the amount of money remaining after all of Repligen operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Repligen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Repligen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (25.51 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Repligen Net Income Regression Statistics
| Arithmetic Mean | (67,354,878) | |
| Coefficient Of Variation | (596.63) | |
| Mean Deviation | 181,796,485 | |
| Median | 14,156,037 | |
| Standard Deviation | 401,858,560 | |
| Sample Variance | 161490.3T | |
| Range | 1.8B | |
| R-Value | 0.37 | |
| Mean Square Error | 148754.8T | |
| R-Squared | 0.14 | |
| Significance | 0.14 | |
| Slope | 29,394,341 | |
| Total Sum of Squares | 2583844.8T |
Repligen Net Income History
Other Fundumenentals of Repligen
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Repligen Net Income component correlations
Repligen Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Repligen is extremely important. It helps to project a fair market value of Repligen Stock properly, considering its historical fundamentals such as Net Income. Since Repligen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Repligen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Repligen's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.
Repligen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Repligen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Repligen.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Repligen on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Repligen or generate 0.0% return on investment in Repligen over 90 days. Repligen is related to or competes with Avantor, Masimo, Baxter International, AptarGroup, Bio Rad, DaVita HealthCare, and Charles River. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manuf... More
Repligen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Repligen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Repligen upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 10.06 | |||
| Value At Risk | (3.33) | |||
| Potential Upside | 3.1 |
Repligen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Repligen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Repligen's standard deviation. In reality, there are many statistical measures that can use Repligen historical prices to predict the future Repligen's volatility.| Risk Adjusted Performance | 0.0017 | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.02) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Repligen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Repligen February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0017 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 1.65 | |||
| Coefficient Of Variation | (17,674) | |||
| Standard Deviation | 2.15 | |||
| Variance | 4.63 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.26) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 10.06 | |||
| Value At Risk | (3.33) | |||
| Potential Upside | 3.1 | |||
| Skewness | 0.1423 | |||
| Kurtosis | 0.1662 |
Repligen Backtested Returns
Repligen maintains Sharpe Ratio (i.e., Efficiency) of -0.0664, which implies the firm had a -0.0664 % return per unit of risk over the last 3 months. Repligen exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Repligen's Risk Adjusted Performance of 0.0017, variance of 4.63, and Coefficient Of Variation of (17,674) to confirm the risk estimate we provide. The company holds a Beta of 1.46, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Repligen will likely underperform. At this point, Repligen has a negative expected return of -0.14%. Please make sure to check Repligen's jensen alpha, kurtosis, as well as the relationship between the Kurtosis and period momentum indicator , to decide if Repligen performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.1 |
Very weak reverse predictability
Repligen has very weak reverse predictability. Overlapping area represents the amount of predictability between Repligen time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Repligen price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Repligen price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 87.8 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Repligen Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Repligen reported net income of (25.51 Million). This is 107.48% lower than that of the Life Sciences Tools & Services sector and 125.61% lower than that of the Health Care industry. The net income for all United States stocks is 104.47% higher than that of the company.
Repligen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.Repligen is currently under evaluation in net income category among its peers.
Repligen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Repligen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Repligen's managers, analysts, and investors.Environmental | Governance | Social |
Repligen Institutional Holders
Institutional Holdings refers to the ownership stake in Repligen that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Repligen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Repligen's value.| Shares | Brown Capital Management, Llc | 2025-06-30 | 1 M | Geode Capital Management, Llc | 2025-06-30 | 980.7 K | Conestoga Capital Advisors, Llc | 2025-06-30 | 976.9 K | Holocene Advisors, Lp | 2025-06-30 | 936.8 K | Alliancebernstein L.p. | 2025-06-30 | 906.4 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 768 K | Impax Asset Management Group Plc | 2025-06-30 | 761 K | Millennium Management Llc | 2025-06-30 | 701.2 K | New York State Common Retirement Fund | 2025-06-30 | 606 K | T. Rowe Price Associates, Inc. | 2025-06-30 | 6.6 M | Blackrock Inc | 2025-06-30 | 6.1 M |
Repligen Fundamentals
| Return On Equity | 9.0E-4 | ||||
| Return On Asset | 0.013 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.03 B | ||||
| Shares Outstanding | 56.29 M | ||||
| Shares Owned By Insiders | 6.33 % | ||||
| Shares Owned By Institutions | 93.67 % | ||||
| Number Of Shares Shorted | 3.92 M | ||||
| Price To Earning | 154.58 X | ||||
| Price To Book | 3.88 X | ||||
| Price To Sales | 11.42 X | ||||
| Revenue | 634.44 M | ||||
| Gross Profit | 365.19 M | ||||
| EBITDA | 80.26 M | ||||
| Net Income | (25.51 M) | ||||
| Cash And Equivalents | 596.51 M | ||||
| Cash Per Share | 10.75 X | ||||
| Total Debt | 686.25 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 37.01 X | ||||
| Cash Flow From Operations | 175.39 M | ||||
| Short Ratio | 6.47 X | ||||
| Earnings Per Share | 0.01 X | ||||
| Price To Earnings To Growth | 2.59 X | ||||
| Target Price | 190.89 | ||||
| Number Of Employees | 1.78 K | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 8.08 B | ||||
| Total Asset | 2.83 B | ||||
| Retained Earnings | 407.35 M | ||||
| Working Capital | 939.25 M | ||||
| Current Asset | 103.25 M | ||||
| Current Liabilities | 18.78 M | ||||
| Net Asset | 2.83 B |
About Repligen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Repligen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repligen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will appreciate offsetting losses from the drop in the long position's value.Moving against Repligen Stock
The ability to find closely correlated positions to Repligen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repligen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repligen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repligen to buy it.
The correlation of Repligen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repligen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repligen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repligen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.